Article
Efficacy and Safety of Remimazolam Mesylate in General Anesthesia Induction and Maintenance in Elderly Patients: A Single-Center, Randomized, Positive-Drug, Paralleled, Controlled Study
2022-08-02
Abstract excerpt
<h4>Objective: </h4> To evaluate the efficacy and safety of remimazolam mesylate for general anesthesia in elderly patients. Methods Patents aged 60 to 80 years who were scheduled to undergo surgery were randomized into three groups: Group A (remimazolam mesylate 6 mg/kg/h), Group B (remimazolam mesylate 12 mg/kg/h), or Group C (propofol 2.0-2.5 mg/kg). Primary efficacy indicators (success rate of anesthesia seda...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 328d72ea-63dd-5726-86f2-1c59a9620ebd
- DOI
- 10.21203/rs.3.rs-1820076/v1
